Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Metagenomi (MGX) Shares Outstanding (Diluted Average) (2023 - 2025)

Metagenomi (MGX) has disclosed Shares Outstanding (Diluted Average) for 3 consecutive years, with $37.3 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Diluted Average) rose 12.79% to $37.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $37.3 million through Dec 2025, up 12.79% year-over-year, with the annual reading at $37.3 million for FY2025, 12.79% up from the prior year.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $37.3 million at Metagenomi, roughly flat from $37.2 million in the prior quarter.
  • The five-year high for Shares Outstanding (Diluted Average) was $37.3 million in Q4 2025, with the low at $3.4 million in Q1 2023.
  • Average Shares Outstanding (Diluted Average) over 3 years is $24.1 million, with a median of $34.8 million recorded in 2024.
  • The sharpest move saw Shares Outstanding (Diluted Average) surged 979.91% in 2024, then increased 1.12% in 2025.
  • Over 3 years, Shares Outstanding (Diluted Average) stood at $3.4 million in 2023, then skyrocketed by 870.1% to $33.0 million in 2024, then increased by 12.79% to $37.3 million in 2025.
  • According to Business Quant data, Shares Outstanding (Diluted Average) over the past three periods came in at $37.3 million, $37.2 million, and $37.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.